[1] Stubbs P,Seed M,Lane D,et al.Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes[J].Eur Heart J,1998,19(9):1355-1364.
[2] Haider AW,Andreotti F,Thompson GR,et al.Serum lipoprotein(a) level is related to hrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction[J].Circulation,1996,94(9):2072-2076.
[3] Ornek E,Murat S,Duran M,et al.The relationship between lipoprotein(a) and coronary artery disease,as well as its variable nature following myocardial infarction[J].Clin Invest Med,2011,34(1):14-20.
[4] Tsironis LD,Mitsios JV,Milionis HJ,et al.Effect of lipoprotein(a) on platelet activation induced by platelet-activating factor:role of apolipoprotein(a) and endogenous PAF-acetylhydrolase[J].Cardiovasc Res,2004,63(1):130-138.
[5] Jones SR,Blumenthal RS.Lipoprotein(a) measurement and determining risk of myocardial infarction[J].JAMA,2009,301(22):1654-1655.
[6] Moliterno DJ,Lange RA,Meidell RS,et al.Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction[J].Circulation,1993,88(3):935-940.
[7] Von Hodenberg E,Pestel E,Kreuzer J,et al.Effects of lipoprotein(a) on thrombolysis[J].Chem Phys Lipids,1994(67/68):381-385.
[8] Barghash NA,Elewa SM,Hamdi EA,et al.Role of plasma homocysteine and lipoprotein(a) in coronary artery disease[J].Br J Biomed Sci,2004,61(2):78-83.
[9] Biemond BJ,Friederich PW,Koschinsky ML,et al.Apolipoprotein(a) attenuates endogenous fibrinolysis in rabbit jugular vein thrombsis model in vivo[J].Circulation,1997,96(5):1612-1615.